Iridex Corp
IRIX- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001006045
In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Iridex Corp as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −4 vs. Q1 2025
- Shares held
- 2.69M
- −456.9K (−14.5%) vs. Q1 2025
- Total value
- $2.37M
- −$819.9K (−25.7%) vs. Q1 2025
- New holders
- 3
- 2 more added
- Sold out
- 7
- 8 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IRIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $2.47M |
| Q1 2026 | 25 | $2.92M |
| Q4 2025 | 22 | $3.19M |
| Q3 2025 | 22 | $3.24M |
| Q2 2025 | 20 | $2.37M |
| Q1 2025 | 24 | $3.19M |
| Q4 2024 | 27 | $5.43M |
| Q3 2024 | 28 | $5.83M |
| Q2 2024 | 29 | $7.08M |
| Q1 2024 | 30 | $9.90M |
| Q4 2023 | 32 | $9.17M |
| Q3 2023 | 31 | $9.03M |
| Q2 2023 | 28 | $8.43M |
| Q1 2023 | 31 | $7.56M |
| Q4 2022 | 26 | $7.23M |
| Q3 2022 | 28 | $8.51M |
| Q2 2022 | 30 | $9.07M |
| Q1 2022 | 32 | $17.0M |
| Q4 2021 | 32 | $21.4M |
| Q3 2021 | 29 | $26.8M |
| Q2 2021 | 33 | $27.2M |
| Q1 2021 | 29 | $26.0M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Iridex Corp; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 123 | $109 | 0.00% | +15+13.9% | Added |
| Raymond James Financial Inc | 700 | $617 | 0.00% | +700 | New |
| Group One Trading, L.P. | 1,100 | $971 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 5,464 | $4.82K | 0.00% | −497−8.3% | Reduced |
| HighTower Advisors, LLC | 10,000 | $8.82K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 20,260 | $17.9K | 0.00% | −36,408−64.2% | Reduced |
| Northern Trust Corp | 24,905 | $22.0K | 0.00% | −286−1.1% | Reduced |
| XTX Topco Ltd | 25,211 | $22.3K | 0.00% | +14,900+144.5% | Added |
| Citadel Advisors LLC | 31,171 | $27.5K | 0.00% | −43,077−58.0% | Reduced |
| Bank of New York Mellon Corp | 31,540 | $27.8K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 38,636 | $34.1K | 0.00% | +38,636 | New |
| State Street Corp | 44,718 | $39.5K | 0.00% | 00.0% | Unchanged |
| Perkins Capital Management Inc | 47,300 | $41.7K | 0.04% | 00.0% | Unchanged |
| Thompson Davis & Co., Inc. | 56,726 | $50.0K | 0.03% | +56,726 | New |
| Apexium Financial, LP | 65,695 | $58.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 131,767 | $116.3K | 0.00% | −1,338−1.0% | Reduced |
| AMH Equity Ltd | 190,000 | $167.6K | 0.25% | −328,541−63.4% | Reduced |
| Renaissance Technologies LLC | 378,760 | $334.0K | 0.00% | −400−0.1% | Reduced |
| Vanguard Group Inc | 585,813 | $517.3K | 0.00% | −8,974−1.5% | Reduced |
| Paragon Associates & Paragon Associates II Joint Venture | 1,000,000 | $880.0K | 1.40% | 00.0% | Unchanged |
| ARS Investment Partners, LLC | 0 | $0 | 0.00% | −110,060−100.0% | Sold out |
| Concurrent Investment Advisors, LLC | 0 | $0 | 0.00% | −21,944−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −14,549−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,502−100.0% | Sold out |
| West Paces Advisors Inc. | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −125−100.0% | Sold out |